Knoll Capital Management, LLC
MIAMI, FL · CIK 1325083 · 13F filing filed 2024-08-14
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
$148.4m
reported value
-7.7% vs Q1 2024
35positions
74.0%in top 10
1 new
2 added
0 reduced
0 sold out
vs Q1 2024
Holdings, Q2 2024
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| APPLIED THERAPEUTICS INC APLT | $26.0m17.54% | Unchanged |
| BIOHAVEN PHARMACTL HLDG CO L BHVN | $24.7m16.62% | Added +220.0k |
| ALDEYRA THERAPEUTICS INC ALDX | $18.1m12.21% | Unchanged |
| AVADEL PHARMACEUTICALS PLC SPONSORED ADR | $8.4m5.68% | Unchanged |
| ALTIMMUNE INC ALT | $7.5m5.03% | Added +554.3k |
| ENTERA BIO LTD ENTX | $7.1m4.81% | Unchanged |
| SPDR GOLD TR GLD | $6.9m4.64% | Unchanged |
| SILVERCREST METALS INC SIL | $3.8m2.58% | Unchanged |
| KINROSS GOLD CORP KGC | $3.7m2.47% | Unchanged |
| AGNICO EAGLE MINES LTD AEM | $3.6m2.45% | Unchanged |
| SEABRIDGE GOLD INC COM | $3.4m2.27% | Unchanged |
| HOOKIPA PHARMA INC COM | $3.3m2.20% | Unchanged |
| MAG SILVER CORP MAG | $3.2m2.16% | Unchanged |
| WHEATON PRECIOUS METALS CORP WPM | $3.1m2.12% | Unchanged |
| FRANCO NEV CORP FNV | $3.0m2.00% | Unchanged |
| VERONA PHARMA PLC VRNA | $2.9m1.95% | Unchanged |
| EQUINOX GOLD CORP EQX | $2.9m1.94% | Unchanged |
| BOOZ ALLEN HAMILTON HLDG COR BAH | $2.0m1.35% | Unchanged |
| GLOBAL X FDS SIL | $1.4m0.95% | Unchanged |
| OCULAR THERAPEUTIX INC OCUL | $1.4m0.92% | Unchanged |
| ISHARES SILVER TR SLV | $1.3m0.87% | Unchanged |
| VISA INC V | $1.3m0.86% | Unchanged |
| ALAMOS GOLD INC NEW AGI | $1.3m0.85% | Unchanged |
| PHILIP MORRIS INTL INC PM | $1.0m0.68% | Unchanged |
| ISHARES TR ITA | $1.0m0.68% | Unchanged |
| ROYAL GOLD INC RGLD | $945.0k0.64% | Unchanged |
| NORTHROP GRUMMAN CORP NOC | $943.8k0.64% | Unchanged |
| MEREO BIOPHARMA GROUP PLC MREO | $937.7k0.63% | Unchanged |
| CVS HEALTH CORP CVS | $856.7k0.58% | Unchanged |
| DIAGEO PLC DEO | $851.0k0.57% | Unchanged |
| NEW PAC METALS CORP NEWP | $727.5k0.49% | Unchanged |
| Orgenesis, Inc. COM | $380.8k0.26% | Unchanged |
| SKEENA RES LTD NEW SKE | $208.3k0.14% | Unchanged |
| CARDIOL THERAPEUTICS INC CRDL | $202.0k0.14% | New |
| OPUS GENETICS INC IRD | $153.0k0.10% | Unchanged |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| ELICIO THERAPEUTICS INC ELTX · 13G · filed 2026-07-08 | 5.3%≈ $4.7m |